Related Experiment Video
Updated: Sep 3, 2025

Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function
Published on: February 16, 2017
Detection and Characterization of Paraproteinemia in Canine Chronic B-cell Lymphocytic Leukemia Using Routine and
R Adam Harris1, Erik B Gary1, Emily D Rout1
1Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Most dogs with chronic B-cell lymphocytic leukemia (B-CLL) have a monoclonal protein (M-protein), often IgM, even without hyperproteinemia. Further research is needed on the prognostic impact of heavy and free light chains (fLCs).
Area of Science:
- Veterinary Hematology
- Canine Oncology
- Immunoglobulin Analysis
Background:
- Hyperglobulinemia occurs in 26% of canine chronic B-cell lymphocytic leukemia (B-CLL) cases.
- Monoclonal protein (M-protein) incidence in B-CLL is poorly understood using protein electrophoresis and immunofixation (IF).
Purpose of the Study:
- Determine the proportion of canine B-CLL cases with M-protein using plasma protein electrophoresis (PPE) and routine/free light chain (fLC) IF.
- Assess MUM1/IRF4 expression in productive B-CLL cases via cell tube block (CTB).
Main Methods:
- Analyzed 48 canine B-CLL plasma samples using PPE and routine/fLC IF.
- Diagnosed B-CLL via peripheral blood flow cytometry.
- Performed CTB on 15 additional patients.
Main Results:
- M-protein detected in 67% (32/48) of B-CLL cases; hyperproteinemia present in 35% (17/48).
- IgM was the most common isotype; a subset had detectable fLCs.
- PAX5 was consistently expressed, MUM1/IRF4 was not; CD21+ cell counts higher with detectable M-protein.
Conclusions:
- The majority of canine B-CLL cases exhibit an M-protein, frequently IgM, irrespective of hyperproteinemia.
- A significant subset of cases presented with detectable free light chains (fLCs).
- Prognostic implications of heavy and fLC presence warrant further investigation.
More Related Videos
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016